Rigel Pharmaceuticals, Inc.
RIGL
$26.55
$0.602.31%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
3/14/2026
-
MarketBeat
3/10/2026
-
SeekingAlpha
3/10/2026
-
Seeking Alpha - Healthcare
3/10/2026
-
Seeking Alpha - Long Ideas
Assessing Rigel Pharmaceuticals (RIGL) Valuation After Strong Q4 And Full Year 2025 Earnings Results
3/7/2026
-
Simply Wall St
3/7/2026
-
Ticker Report
3/6/2026
-
Tickeron - Technical Analysis
3/5/2026
-
Tickeron - Technical Analysis
3/5/2026
-
Tickeron - Technical Analysis
3/5/2026
-
TipRanks Financial Blog
3/4/2026
-
Simply Wall St
3/4/2026
-
Ticker Report
3/4/2026
-
MarketBeat
3/4/2026
-
Market News Video
3/4/2026
-
Tickeron - Technical Analysis
3/4/2026
-
Tickeron - Technical Analysis
3/4/2026
-
MarketBeat
3/4/2026
-
SeekingAlpha
3/4/2026
-
Seeking Alpha: Transcripts
3/3/2026
-
SeekingAlpha
3/3/2026
-
MarketBeat
3/3/2026
-
Zacks Investment Research
3/3/2026
-
Benzinga
3/3/2026
-
MarketBeat
3/3/2026
-
TipRanks Financial Blog
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Tuesday, March 3, 2026
Period Date
Wednesday, December 31, 2025
Next Filing
Week of May 4 and 8 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
650 624 1100
Address
611 Gateway Boulevard
South San Francisco, CA 94080
South San Francisco, CA 94080
Country
Year Founded
Business Description
Sector
Rigel Pharmaceuticals, Inc., a biotechnology company, develops and provides therapies that enhance the lives of patients with hematologic disorders and cancer in the United States. The company...
more